“Since 2000, we have worked with the WHO to provide free treatment to leprosy
patients globally, but we know that no single actor – no matter how committed to
patients – can eliminate this debilitating disease alone,” said Joseph Jimenez, CEO of
Novartis. “We are proud to work with governments, international agencies,
nongovernmental organizations and the private sector to ensure that patients receive
the treatment they need. Only with effective and coordinated action by all parties
involved can we achieve our common goal of making leprosy history.”